“G-Protein Coupled Receptors (GPCRs): A Potential Target of Apigenin As a Novel HACE2 Receptor Specific Therapeutic for Impeding Lung Cancer Considering a Group of Missense and Nonsense Mutations in COVID-19 Patients”. European Journal of Pharmaceutical Research 5, no. 1 (May 13, 2025): 6–15. Accessed October 18, 2025. https://www.ej-pharma.org/index.php/pharma/article/view/85.